Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Discovery, development and commercialization of pharmaceutical products for the treatment of human1.65M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States1.2M100.00%